Moleculin Biotech Surges 16.8% as MIRACLE Trial Milestone Sparks Investor Confidence
Explore Moleculin Biotech’s 16.8% surge, MIRACLE trial breakthrough and upcoming reverse split—discover how this Texas biotech could reshape its growth trajectory.
- MOLECULIN BIOTECH INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read